Delivery Order SPE2DB20D1100-SPE2DB25FA7X3
Award Date
2/26/25
Potential Completion Date
2/27/25
Potential Value
$62K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, valued at $9,769.28, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fenofibrate 145 mg tablets, a medication used to treat high cholesterol and triglyceride levels. The contract is a Firm Fixed Price Delivery Order, with a period of performance through January 18, 2024. The contract has no set-aside designation, indicating open...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,311.20 firm-fixed-price delivery order contract is for the supply of 4565427386 - Fenofibrate 145 MG Tablet 90s. The contract has an ultimate completion date of August 13, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves...
This federal contract award, with a ceiling value of $4,641.83, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order for the supply of 4,563,144,691 units of Fenofibrate 145 mg tablets, with an ultimate completion date of December 20, 2023. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award, valued at $1,021.66, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Fenofibrate 145 mg Tablet UD 30s, a generic pharmaceutical product. The award is not designated as a set-aside contract. It represents a single delivery order against a larger Indefinite Delivery Contract (IDC) held by Amerisourcebergen's parent company, Cencora,...
This federal contract award is a delivery order issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Cencora, Inc. The contract, valued at $29,773.32, is for the delivery of Fenofibrate 145 mg Tablets, a prescription medication used to treat high cholesterol and triglyceride levels. The contract is a firm-fixed-price delivery order, with a period of performance through September 21, 2023. It is not designated as a set-aside contract. Amerisourcebergen Drug...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $4,836.58, is for the delivery of Fenofibrate 145 mg tablets in quantities of 500 per bottle. The contract is a firm fixed-price delivery order with a period of performance through February 24, 2025. This award is part of Amerisourcebergen's larger Indefinite Delivery Contract (IDC) with the DLA...
This federal contract award is for the delivery of Fenofibrate 145 mg tablets in 90-count packages. The contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The contract is a Delivery Order with a Firm Fixed Price pricing type, valued at $22,636.70, and has a completion date of February 3, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the supply of Fenofibrate 48 mg tablets. The contract has a ceiling value of $1,713.70 and is a firm fixed price delivery order with an ultimate completion date of August 22, 2024. The contract is not set aside and is part of a larger Indefinite Delivery Contract (IDC) valued up to $999,999,999 with the DLA Troop Support Medical for the delivery of a wide...
This federal contract award, with ID SPE2DB20D2002|SPE2DB24FL25Q, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,553.99 firm fixed-price delivery order is for the supply of 4563689488 Fenofibrate 145 mg tablets, with a completion date of February 20, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
The Defense Logistics Agency (DLA) Troop Support Medical awarded a $3,410.24 firm fixed price delivery order (SPE2DB22D3011|SPE2DB24FQ0PL) to AmerisourceBergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the supply of 4564261717 Fenofibrate 145 mg Tablets. This delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 awarded to AmerisourceBergen Drug Corp to provide a comprehensive range of pharmaceutical products and...